Reardon Andrew Insider Trades & Stock Holdings

CLO & Secretary · Ligand Pharmaceuticals Incorporated · Latest filing Oct 2, 2026

Reardon Andrew, CLO & Secretary at Ligand Pharmaceuticals Incorporated has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.52M), net -$1.52M. Latest filing: disposed of 5K shares of $LGND on Oct 2, 2026 at $304.07.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.52M

Net open-market

-$1.52M

Latest filing

Oct 2, 2026

All insider trades by Reardon Andrew

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$LGND	Sell (Open-market sale) 10b5-1	5K	$304.07	$1.52M			-0.4%			CLO & Secretary		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Reardon Andrew traded

• $LGND

Frequently asked questions

Has Reardon Andrew been buying or selling stock?

Reardon Andrew has 0 open-market purchases and 1 open-market sale on file, net -$1.52M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Reardon Andrew's latest insider trade?

disposed of 5K shares of $LGND on Oct 2, 2026 at $304.07.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.